Zydus Receives Approval for Isotretinoin Capsules

  Published 1 year ago

Zydus Lifesciences received US approval for its generic Isotretinoin capsules, a treatment for severe acne similar to Absorica. The US market reached $115.4M in sales (MAT 2025), marking Zydus's 427th approval.

  • Generic equivalent of Absorica capsules.
  • Treats severe nodular acne.
  • $115.4M US annual sales (2025).

You might like these

L&T Secures Major Transmission Projects in India & Middle East

Zerodha FY25 Earnings Slip Due to Rules

Reliance Infra Gets Ratings Upgrade

Patel Engg Wins NHPC Hydro Project

Karnataka Bank Executives Resign, Stock Falls 4.4%

Indian Oil Pushes SAF, Green Hydrogen

CAMS Q2 FY26 Performance Soars

News that matters the most ⚡